From: An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames predictive potential
Set
Description
Number of molecules
Number of Ames+
Number of Ames-
Aryl-amines Only
A
Novartis 2009
327
72
255
B
Kazius 2005[21]/Hansen 2009[38]
461
134
All compound classes
C
Novartis
2754
360
2394
D
Hansen[38]
6512
3503
3009
E
Marketed Pharmaceuticals[44]
378
44
334
F
Kazius[21]a
4195
2343
1852
Combined C, D, E, and Fa
9423a
3591b
5832b